GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian Cancer

202011 citationsJournal Articlebronze Open Access

Authors

Trabectedin/PLD is a valuable treatment option for partially or fully platinum-sensitive ROC.

Good health and well-being

Published in: Anticancer Research

Volume 40, Issue 7, pp. 3939-3945

Field-Weighted Citation Impact: 1.07